00

Chongqing Sansheng Building Materials Co Ltd

002742 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

3.52CNY-0.04 (-1.12%)

Price History

Full chart

Market Stats

Previous Close3.56
Open3.56
Day Range3.50 – 3.61
52-Week Range3.18 – 6.24
Volume11.86M
Market Cap2.85B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.34
Dividend Yield0.00%
Beta0.43
50-Day Avg4.23
200-Day Avg4.28

About

Chongqing Jiheng Pharmaceutical Co., Ltd. develops, produces and sells building materials and chemicals in China and internationally. It operates through two segments, Buildings Materials Chemical Industry; and Pharmaceutical Manufacturing. The company offers commercial concrete, water reducing agents, and expansion agents for industrial and civil buildings, highways, railways, bridges, tunnels, airports, water conservancy, and hydropower; and sulfuric acid is mainly used in the production of fertilizers and in non-fertilizer acid enterprises such as fertilizers, chemicals, light industry, textile, steel, water reducer, and other non-fertilizer acid enterprises; and concrete admixtures. It also provides pharmaceutical intermediates, such as procaine hydrochloride, cefoxitin acid intermediates, chlorine intermediates, chloramphenicol intermediates, aztreonam intermediates, and orlistat intermediates used in antibiotic drugs, anti-hepatitis C drugs, diabetes drugs, benzathine penicillin and cefoxitin, procaine penicillin, and cosmetics; and API products, including acetaminophen, cloperidine hydrochloride, levofloxacin mesylate, benolate, and diphenhydramine hydrochloride. In addition, the company offers preparation products comprising compound acetaminophen and diphenhydramine tablets, clopidogrel hydrochloride tablets, clarithromycin sustained-release tablets, diclofenac sodium enteric-coated tablets, acetaminophen tablets, and famotidine tablets used in antipyretic and analgesic, antiviral, antibacterial, cough, allergy, local anesthesia; and famotidine, diclofenac sodium, nifedipine, acetaminophen, furosemide, norfloxacin used in clinical drugs to meet basic drug needs. The company was formerly known as Chongqing Sansheng Industrial Co.,Ltd. and changed its name to Chongqing Jiheng Pharmaceutical Co., Ltd. in June 2026. Chongqing Jiheng Pharmaceutical Co., Ltd. was incorporated in 2002 and is headquartered in Chongqing, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Zhongqiang Huang
  • Employees979
  • HeadquartersNo. 19-2, Yunquan Road, Chongqing, China, 400799, China
  • Websitehttps://www.cqssgf.com

Leadership

  • Mr. Zhongqiang HuangGeneral Manager · b. 1974
  • Mr. Xiao ZhangBoard Secretary · b. 1983
  • Mr. Xuying GaoDeputy General Manager · b. 1972

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue847.78M1.06B1.17B1.27B1.41B1.51B1.90B2.87B3.18B2.55B2.49B2.08B2.03B1.20B899.85M
Growth (%)-+25.24%+10.57%+8.25%+11.02%+7.23%+25.76%+50.61%+10.99%-19.83%-2.37%-16.56%-2.25%-41.10%-24.74%
Cost of Revenue674.83M944.47M1.06B1.03B1.11B1.15B1.44B2.19B2.54B1.96B2.08B1.77B1.65B998.94M758.75M
Gross Profit172.95M117.27M109.13M245.03M305.27M366.10M459.79M671.40M635.26M585.65M405.41M307.68M380.04M196.78M141.10M
Gross Margin20.40%11.04%9.30%19.28%21.64%24.20%24.17%23.43%19.98%22.97%16.29%14.81%18.72%16.46%15.68%
Operating Expense70.46M01126.33M161.67M224.92M249.12M497.24M461.64M471.30M712.15M511.34M656.40M764.52M240.23M
Operating Income102.49M117.27M109.13M118.70M143.61M141.18M210.67M174.16M173.62M114.35M-306.74M-203.66M-276.35M-567.74M-99.14M
Operating Margin12.09%11.04%9.30%9.34%10.18%9.33%11.07%6.08%5.46%4.49%-12.32%-9.81%-13.61%-47.48%-11.02%
EBITDA154.61M139.61M151.46M220.98M243.35M258.84M405.78M462.55M476.21M429.34M-26.14M64.08M-32.24M-307.09M-142.35M
EBITDA Margin18.24%13.15%12.90%17.39%17.25%17.11%21.33%16.14%14.97%16.84%-1.05%3.09%-1.59%-25.68%-15.82%
Net Income87.23M102.48M102.55M101.06M121.76M117.91M180.33M110.84M124.84M73.44M-333.44M-317.88M-452.05M-650.13M-419.68M
Net Income Margin10.29%9.65%8.74%7.95%8.63%7.79%9.48%3.87%3.93%2.88%-13.40%-15.30%-22.27%-54.37%-46.64%
R&D---7.39M9.08M14.99M25.21M34.05M34.10M31.83M27.50M9.42M17.37M20.87M17.88M
R&D as % of Total Revenue---0.58%0.64%0.99%1.33%1.19%1.07%1.25%1.10%0.45%0.86%1.75%1.99%
Interest Expense10.52M13.98M25.02M36.98M30.98M38.28M67.19M141.92M140.39M156.38M167.18M172.27M169.22M208.06M201.44M
Interest Expense % of Total Revenue1.24%1.32%2.13%2.91%2.20%2.53%3.53%4.95%4.41%6.13%6.72%8.29%8.33%17.40%22.39%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets734.00M885.59M1.29B1.45B2.14B2.80B4.24B5.04B5.03B4.88B4.41B4.04B3.84B2.63B1.20B
Total Liabilities334.92M381.62M691.94M764.18M909.54M1.45B2.60B3.28B3.22B3.12B3.10B3.05B3.28B2.86B956.46M
Total Equity399.08M503.96M593.95M682.31M1.22B1.30B1.42B1.51B1.55B1.52B1.12B802.31M345.29M-411.81M168.38M
Cash73.63M101.87M135.04M126.75M355.85M264.66M454.59M380.62M440.00M345.68M180.03M117.74M91.46M88.87M114.49M
Total Debt201.25M248.36M363.96M355.44M365.45M758.11M1.47B1.58B1.47B1.18B1.07B1.11B1.08B608.23M-
Net Debt127.62M146.49M228.92M228.69M9.60M493.45M1.02B1.20B1.03B836.74M889.28M991.83M983.89M519.36M387.04M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow33.30M23.51M-47.28M-118.95M56.08M125.12M179.35M-85.46M154.66M140.90M139.84M49.12M-51.59M-47.02M-25.87M
Investing Cash Flow-53.47M-33.22M-85.95M-31.04M-201.95M-476.37M-857.36M-535.87M-34.24M-158.72M-11.32M31.04M-50.08M-41.80M-
Financing Cash Flow46.41M32.45M157.78M81.13M381.61M273.72M728.08M474.47M-145.26M33.82M-149.51M-28.74M70.69M104.86M-
Capital Expenditure53.55M32.82M101.96M42.47M148.65M245.74M309.92M203.00M410.82M94.55M98.80M44.24M46.47M58.41M9.42M
Free Cash Flow-20.25M-9.31M-149.23M-161.42M-92.57M-120.62M-130.58M-288.47M-256.16M46.35M41.03M4.87M-98.07M-105.43M-35.29M
Dividends Paid10.37M13.57M36.43M48.91M45.21M71.50M83.60M123.23M43.20M17.28M148.99M62.49M22.85M8.36M17.08M
FCF to OCF-60.81%-39.58%315.66%135.70%-165.08%-96.41%-72.81%337.53%-165.62%32.89%29.34%9.92%190.07%224.23%136.40%
Dividend Paid to FCF-51.19%-145.75%-24.41%-30.30%-48.83%-59.28%-64.03%-42.72%-16.86%37.28%363.10%1281.99%-23.30%-7.93%-48.39%

Earnings

Report DateMar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Apr 26, 2016Aug 17, 2016Oct 27, 2016Jan 25, 2017Apr 28, 2017Aug 11, 2017Oct 25, 2017Feb 22, 2018Apr 24, 2018Aug 21, 2018Oct 21, 2018Dec 31, 2018Apr 22, 2019Jun 30, 2019Sep 30, 2019Mar 31, 2020Apr 29, 2020Aug 25, 2020Oct 23, 2020Mar 22, 2021Apr 28, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Jun 6, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Jun 6, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------
EPS Actual0.060.070.060.090.060.080.040.100.060.230.020.110.080.080.030.060.080.090.010.100.050.060.000.060.06-0.10-0.06-0.670.01-0.11-0.09-0.55-0.08-0.15-0.08-0.74-0.08-0.070.06-1.41-0.19-0.11-0.11-0.35-0.01-0.02
Surprise----------------------------------------------
Timing----Pre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-market-Pre-market-------------------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap2.85B
Enterprise Value3.32B
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.35
Price / Book19.43
EPS-0.34
Book Value0.217
Revenue (TTM)654.22M
Gross Profit (TTM)59.85M
EBITDA-30.22M
Profit Margin-47.21%
Operating Margin-3.85%
Return on Equity-8922.76%
Return on Assets-3.57%
Shares Outstanding684.10M
Shares Float616.31M
Beta0.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20201×
0.04Jul 1, 2020
20191×
0.10Aug 22, 2019
20181×
0.07May 11, 2018
20171×
0.07May 12, 2017
20161×
0.08May 24, 2016
20151×
0.03May 20, 2015

Stock Splits

  • Sep 8, 201720:10
  • May 24, 201615:10
  • May 20, 201515:10